News

Discover how a collaboration delivered bit.bio's ioGlutamatergic Neurons onto the stage at the Royal Institution to appear in the ...

bit.bio received a gold award for its participation in the Green Impact awards for sustainability.

bit.bio's President and COO named as one of the 20 women reshaping biopharma R&D in 2023 report.

An article on synbio in the Summer 2023 issue of Science in Parliament magazine. Authored by our founder and CEO Mark Kotter.

bit.bio is partnering with the iGEM student competition, aimed at advancing the field of synthetic biology.

Our VP of R&D Manos Metzakopian writes in Innovations in Pharmaceutical Technology about novel technologies that enable researcher...

Device that could restore limb function to amputees and others who have lost the use of their arms or legs uses opti-ox reprogramm...

Our CEO was interviewed in this piece about the barriers and opportunities for scaling companies in the UK.